Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection von Lawitz, Eric, Mangia, Alessandra, Wyles, David, Rodriguez-Torres, Maribel, Hassanein, Tarek, Gordon, Stuart C, Schultz, Michael, Davis, Mitchell N, Kayali, Zeid, Reddy, K. Rajender, Jacobson, Ira M, Kowdley, Kris V, Nyberg, Lisa, Subramanian, G. Mani, Hyland, Robert H, Arterburn, Sarah, Jiang, Deyuan, McNally, John, Brainard, Diana, Symonds, William T, McHutchison, John G, Sheikh, Aasim M, Younossi, Zobair, Gane, Edward J

Volltext

The Evolving Challenge of Infections in Cirrhosis von Bajaj, Jasmohan S, Kamath, Patrick S, Reddy, K. Rajender

Volltext

Terlipressin plus Albumin for the Treatment of Type 1 Hepatorenal Syndrome von Wong, Florence, Pappas, S. Chris, Curry, Michael P, Reddy, K. Rajender, Rubin, Raymond A, Porayko, Michael K, Gonzalez, Stevan A, Mumtaz, Khalid, Lim, Nicholas, Simonetto, Douglas A, Sharma, Pratima, Sanyal, Arun J, Mayo, Marlyn J, Frederick, R. Todd, Escalante, Shannon, Jamil, Khurram

Volltext

Ledipasvir and Sofosbuvir for 8 or 12 Weeks for Chronic HCV without Cirrhosis von Kowdley, Kris V, Gordon, Stuart C, Reddy, K. Rajender, Rossaro, Lorenzo, Bernstein, David E, Lawitz, Eric, Shiffman, Mitchell L, Schiff, Eugene, Ghalib, Reem, Ryan, Michael, Rustgi, Vinod, Chojkier, Mario, Herring, Robert, Di Bisceglie, Adrian M, Pockros, Paul J, Subramanian, G. Mani, An, Di, Svarovskaia, Evguenia, Hyland, Robert H, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Pound, David, Fried, Michael W

Volltext

Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection von Sulkowski, Mark S, Gardiner, David F, Rodriguez-Torres, Maribel, Reddy, K. Rajender, Hassanein, Tarek, Jacobson, Ira, Lawitz, Eric, Lok, Anna S, Hinestrosa, Federico, Thuluvath, Paul J, Schwartz, Howard, Nelson, David R, Everson, Gregory T, Eley, Timothy, Wind-Rotolo, Megan, Huang, Shu-Pang, Gao, Min, Hernandez, Dennis, McPhee, Fiona, Sherman, Diane, Hindes, Robert, Symonds, William, Pasquinelli, Claudio, Grasela, Dennis M

Volltext

Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection von Jacobson, Ira M, McHutchison, John G, Dusheiko, Geoffrey, Di Bisceglie, Adrian M, Reddy, K. Rajender, Bzowej, Natalie H, Marcellin, Patrick, Muir, Andrew J, Ferenci, Peter, Flisiak, Robert, George, Jacob, George, Shelley, Rizzetto, Mario, Shouval, Daniel, Sola, Ricard, Terg, Ruben A, Yoshida, Eric M, Adda, Nathalie, Bengtsson, Leif, Sankoh, Abdul J, Kieffer, Tara L, Kauffman, Robert S, M.D, Stefan Zeuzem

Volltext

American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy von Reddy, K. Rajender, Beavers, Kimberly L, Hammond, Sarah P, Lim, Joseph K, Falck-Ytter, Yngve T

Volltext

Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort von Bajaj, Jasmohan S, Garcia-Tsao, Guadalupe, Biggins, Scott W, Kamath, Patrick S, Wong, Florence, McGeorge, Sara, Shaw, Jawaid, Pearson, Meredith, Chew, Micheal, Fagan, Andrew, de la Rosa Rodriguez, Randolph, Worthington, Janelle, Olofson, Amy, Weir, Vanessa, Trisolini, Calvin, Dwyer, Sarah, Reddy, K Rajender

Volltext

Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trial von Navarro, Victor J, Belle, Steven H, D'Amato, Massimo, Adfhal, Nezam, Brunt, Elizabeth M, Fried, Michael W, Reddy, K Rajender, Wahed, Abdus S, Harrison, Stephen

Volltext

Clinical Best Practice Advice for Hepatology and Liver Transplant Providers During the COVID‐19 Pandemic: AASLD Expert Panel Consensus Statement von Fix, Oren K., Hameed, Bilal, Fontana, Robert J., Kwok, Ryan M., McGuire, Brendan M., Mulligan, David C., Pratt, Daniel S., Russo, Mark W., Schilsky, Michael L., Verna, Elizabeth C., Loomba, Rohit, Cohen, David E., Bezerra, Jorge A., Reddy, K. Rajender, Chung, Raymond T.

Volltext

Treat chronic hepatitis C virus infection in decompensated cirrhosis - pre- or post-liver transplantation? the ironic conundrum in the era of effective and well-tolerated therapy von Bunchorntavakul, C., Reddy, K. Rajender

Volltext

ABT-450/r–Ombitasvir and Dasabuvir with or without Ribavirin for HCV von Ferenci, Peter, Bernstein, David, Lalezari, Jacob, Cohen, Daniel, Luo, Yan, Cooper, Curtis, Tam, Edward, Marinho, Rui T, Tsai, Naoky, Nyberg, Anders, Box, Terry D, Younes, Ziad, Enayati, Pedram, Green, Sinikka, Baruch, Yaacov, Bhandari, Bal Raj, Caruntu, Florin Alexandru, Sepe, Thomas, Chulanov, Vladimir, Janczewska, Ewa, Rizzardini, Giuliano, Gervain, Judit, Planas, Ramon, Moreno, Christophe, Hassanein, Tarek, Xie, Wangang, King, Martin, Podsadecki, Thomas, Reddy, K. Rajender

Volltext

DAA therapy and long-term hepatic function in advanced/decompensated cirrhosis: Real-world experience from HCV-TARGET cohort von Verna, Elizabeth C., Morelli, Giuseppe, Terrault, Norah A., Lok, Anna S., Lim, Joseph K., Di Bisceglie, Adrian M., Zeuzem, Stefan, Landis, Charles S., Kwo, Paul, Hassan, Mohamed, Manns, Michael P., Vainorius, Monika, Akushevich, Lucy, Nelson, David R., Fried, Michael W., Reddy, K. Rajender

Volltext

Sofosbuvir and Velpatasvir for HCV in Patients with Decompensated Cirrhosis von Curry, Michael P, O’Leary, Jacqueline G, Bzowej, Natalie, Muir, Andrew J, Korenblat, Kevin M, Fenkel, Jonathan M, Reddy, K. Rajender, Lawitz, Eric, Flamm, Steven L, Schiano, Thomas, Teperman, Lewis, Fontana, Robert, Schiff, Eugene, Fried, Michael, Doehle, Brian, An, Di, McNally, John, Osinusi, Anu, Brainard, Diana M, McHutchison, John G, Brown, Robert S, Charlton, Michael

Volltext

Ledipasvir and Sofosbuvir for Previously Treated HCV Genotype 1 Infection von Afdhal, Nezam, Reddy, K. Rajender, Nelson, David R, Lawitz, Eric, Gordon, Stuart C, Schiff, Eugene, Nahass, Ronald, Ghalib, Reem, Gitlin, Norman, Herring, Robert, Lalezari, Jacob, Younes, Ziad H, Pockros, Paul J, Di Bisceglie, Adrian M, Arora, Sanjeev, Subramanian, G. Mani, Zhu, Yanni, Dvory-Sobol, Hadas, Yang, Jenny C, Pang, Phillip S, Symonds, William T, McHutchison, John G, Muir, Andrew J, Sulkowski, Mark, Kwo, Paul

Volltext

Diagnosis and Treatment of Hepatocellular Carcinoma von El-Serag, Hashem B, Marrero, Jorge A, Rudolph, Lenhard, Reddy, K. Rajender

Volltext

Survival in infection‐related acute‐on‐chronic liver failure is defined by extrahepatic organ failures von Bajaj, Jasmohan S., O'Leary, Jacqueline G., Reddy, K. Rajender, Wong, Florence, Biggins, Scott W., Patton, Heather, Fallon, Michael B., Garcia‐Tsao, Guadalupe, Maliakkal, Benedict, Malik, Raza, Subramanian, Ram M., Thacker, Leroy R., Kamath, Patrick S., the North American Consortium for the Study of End-stage Liver Disease (NACSELD)

Volltext

Second infections independently increase mortality in hospitalized patients With cirrhosis: the north american consortium for the study of end-stage liver disease (NACSELD) experie... von Bajaj, Jasmohan S., O'Leary, Jacqueline G., Reddy, K. Rajender, Wong, Florence, Olson, Jody C., Subramanian, Ram M., Brown, Geri, Noble, Nicole A., Thacker, Leroy R., Kamath, Patrick S.

Volltext

Liver injury from herbals and dietary supplements in the U.S. Drug‐Induced Liver Injury Network von Navarro, Victor J., Barnhart, Huiman, Bonkovsky, Herbert L., Davern, Timothy, Fontana, Robert J., Grant, Lafaine, Reddy, K. Rajender, Seeff, Leonard B., Serrano, Jose, Sherker, Averell H., Stolz, Andrew, Talwalkar, Jayant, Vega, Maricruz, Vuppalanchi, Raj

Volltext

A Novel Blood-Based Panel of Methylated DNA and Protein Markers for Detection of Early-Stage Hepatocellular Carcinoma von Chalasani, Naga P., Ramasubramanian, Tiruvidaimarudur S., Bhattacharya, Abhik, Olson, Marilyn C., Edwards V, David K., Roberts, Lewis R., Kisiel, John B., Reddy, K. Rajender, Lidgard, Graham P., Johnson, Scott C., Bruinsma, Janelle J.

Volltext